← FDA Drug Approvals (Drugs@FDA)

YUFLYMA

BLA · Biologics License Application · Sponsor: CELLTRION · Approved 2023-05-23

Drug application

FDA Application #

BLA761219

Application type

Biologics License Application

Brand name

YUFLYMA

Generic name

ADALIMUMAB-AATY

Active ingredients

ADALIMUMAB-AATY

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

CELLTRION

Manufacturer

CELLTRION USA, Inc.

First approval

2023-05-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown